News

Innovation - Products - Social responsibility

Arkema wins European Coating Award 2013

Arkema received the award of best scientific paper at the European Coatings Award 2013 with the presentation "A New Way to Ensure Metal Protection with Waterborne Dispersions".
Innovation - Products - Social responsibility

Arkema launches the Rilsan® T, a new range of biosourced polyamides  

 - Press release
Arkema, the world’s number 1 for specialty polyamides, expands its offering with Rilsan® T range, some new biosourced polyamide 10.10 processed from castor oil. Manufactured at its Serquigny facility in France, it benefits from unrivaled raw material integration, boosted by the recent acquisition of Casda and Hipro as well as a new joint venture with Jayant Agro.
Products

Arkema presents its fine powders for “Laser Sintering” at the AMUG conference  

 - Press release
A world leader in high performance polymers, Arkema offers a diverse range of fine powders for the manufacture of prototypes and functional technical short runs using the laser sintering technology. From 14 to 18th of April in Jacksonville (Florida - USA), Arkema will showcase its powders offer at the AMUG 2013 (Additive Manufacturing Users Group) conference which promotes the uses and applications of additive manufacturing technologies.
Products

Arkema increases the price of Hydrazine Hydrate

Arkema announces a price increase of 200 € per ton (100% concentration basis) for all grades of Hydrazine Hydrate applicable from April 1st, 2013 or as contracts allow.
Products

Arkema launches its specialty polyamides MED grades for medical market and appoints Velox as exclusive distributor for this market in Europe

 - Press release
Arkema is committed to provide the highest quality material for the medical market; this is why almost 10 years ago Arkema began to introduce MED grades for some of its Specialty Polyamides products. An extensive range of MED grades is now available for its main product lines (Pebax® SA 01MED, Rilsan®MED, and Rilsamid®MED) that Arkema will sell exclusively in the medical devices market worldwide.
Corporate - Finance

Arkema confirms its 2016 ambition and presents its roadmap to 2020  

 - Press release
At an Investor Day taking place today in Paris, Arkema presents its 2016 ambition to become a world leader in specialty chemicals and advanced materials. With a selective and profitable growth strategy, the Group targets sales of 8 billion euros and an EBITDA margin of 16% in 2016 while maintaining gearing below 40%.  Beyond, the Group intends to maintain its pace of development and aims to achieve sales of 10 billion euros with an EBITDA margin close to 17% in 2020.Confident in its long term prospects, Arkema announces that its dividend per share will already show a significant step-up in 2012 and targets beyond a 30% payout ratio on adjusted net income.
Corporate

Firmly rooted in chemistry and innovation, performance and leadership: Arkema acquires a new visual identity  

 - Press release
With a renewed focus on specialty chemicals and innovation, Arkema, a global chemical company and France’s leading chemicals producer, now enters into a new phase in its development. Accordingly, the Group is acquiring a new visual identity and a new signature “Innovative Chemistry” which reflects its new positioning in its high added value niches as well as the quality of its innovation.
Corporate - Finance

Arkema announces a project for the divestment of its Tin Stabilizer business  

 - Press release
Arkema has announced a project for the sale of its tin stabilizer business to PMC Group headquartered in Mount Laurel, NJ, a manufacturer of performance chemicals and plastics. With this proposed divestment of organometallic products, including Thermolite® tin stabilizers, Fascat® catalysts, and fine chemicals, Arkema continues to refocus its activities on fast growing core specialty businesses.